Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar;20(3):559-568.e5.
doi: 10.1016/j.cgh.2020.10.037. Epub 2020 Oct 22.

Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease

Affiliations
Randomized Controlled Trial

Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease

Casper Steenholdt et al. Clin Gastroenterol Hepatol. 2022 Mar.

Abstract

Background & aims: Colonoscopy is essential for optimal management of inflammatory bowel disease. However, many patients opt out due to unpleasantness related to this procedure. We investigated if Nurse Administered Propofol Sedation (NAPS) would improve patient satisfaction and attitude towards future colonoscopies.

Methods: Randomized clinical trial of deep sedation with NAPS (n = 63) versus moderate midazolam and fentanyl sedation (n = 67). To assess the primary end point of patient satisfaction at discharge, we developed a Satisfaction Questionnaire comprising 13 items each rated by a 5-point Likert scale and with higher scores reflecting more positive outcomes (13-65 points).

Results: Fifty-six patients (43%) with ulcerative colitis, 48 (37%) with Crohn's disease, and 26 (20%) with high suspicion of inflammatory bowel disease were included. Most (88%) had previously had a colonoscopy and pre-procedure expectations were similar between groups. Patients receiving deep sedation had significantly higher satisfaction score (mean 60.1, SD 3.4) than those receiving moderate sedation (51.2, 8.4; P < .001). This was driven especially by less pain, more amnesia, sedation more to their liking, and better experience with the current than previous sedations. Importantly, these patients significantly more often preferred the same sedation for a future colonoscopy and were also inclined to accept more frequent colonoscopies. Assistance from another colonoscopist and disruption of the procedure due to pain occurred significantly more frequent in the moderate sedation group. There were no safety signals associated with NAPS.

Conclusions: Patients with inflammatory bowel disease favor deep propofol sedation over moderate midazolam and fentanyl sedation. Availability of NAPS may facilitate patient adherence to endoscopy-based monitoring programs. Clinicaltrials.gov NCT01934088.

Keywords: Colonoscopy; IBD; Nurse-Administered Propofol Sedation; Patient-Reported Outcomes; Satisfaction.

PubMed Disclaimer

Comment in

  • Procedural Sedation for Colonoscopy: A Role for Patient-Maintained Propofol Sedation?
    Hewson DW. Hewson DW. Clin Gastroenterol Hepatol. 2022 Jul;20(7):1622. doi: 10.1016/j.cgh.2020.11.026. Epub 2020 Nov 20. Clin Gastroenterol Hepatol. 2022. PMID: 33221549 No abstract available.
  • Reply.
    Steenholdt C, Jensen JT, Vilmann P. Steenholdt C, et al. Clin Gastroenterol Hepatol. 2021 Nov;19(11):2456. doi: 10.1016/j.cgh.2020.12.018. Epub 2020 Dec 15. Clin Gastroenterol Hepatol. 2021. PMID: 33338659 No abstract available.
  • Patient Satisfaction, at What Cost?
    Vaughn BP. Vaughn BP. Clin Gastroenterol Hepatol. 2022 Apr;20(4):e912. doi: 10.1016/j.cgh.2021.04.016. Epub 2021 Apr 20. Clin Gastroenterol Hepatol. 2022. PMID: 33864934 No abstract available.
  • Reply.
    Steenholdt C, Brynskov J, Vilmann P. Steenholdt C, et al. Clin Gastroenterol Hepatol. 2022 Apr;20(4):e912-e913. doi: 10.1016/j.cgh.2021.05.006. Epub 2021 May 6. Clin Gastroenterol Hepatol. 2022. PMID: 33965577 No abstract available.

Publication types

Associated data